Ilo Leppik is a notable inventor based in Minneapolis, MN (US), recognized for his contributions to the field of pharmaceutical formulations. He holds 2 patents that focus on innovative methods for the parenteral administration of carbamazepine, a medication used primarily for epilepsy and bipolar disorder.

Latest Patents

Leppik's latest patents include a parenteral carbamazepine formulation that utilizes a carbamazepine-cyclodextrin inclusion complex. This complex is designed for effective parenteral administration and is prepared by mixing modified cyclodextrins, such as 2-hydroxypropyl-beta-cyclodextrin and sulfoalkyl cyclodextrins, with carbamazepine in a physiologically acceptable fluid. The fluids suitable for this formulation include sterile isotonic water, Ringer's lactate, D5W (5% dextrose in water), and physiological saline.

Career Highlights

Throughout his career, Ilo Leppik has worked with prominent companies in the pharmaceutical industry, including Lundbeck Pharmaceuticals LLC and Lundbeck Inc. His work has significantly impacted the development of formulations that enhance the delivery and efficacy of medications.

Collaborations

Leppik has collaborated with esteemed professionals in his field, including James C Cloyd and Angela Birnbaum. These collaborations have contributed to the advancement of research and development in pharmaceutical formulations.

Conclusion

Ilo Leppik's innovative work in parenteral formulations showcases his dedication to improving medication delivery systems. His contributions continue to influence the pharmaceutical industry and enhance patient care.

This text is generated by artificial intelligence and may not be accurate.